NEW YORK, Nov. 19, 2022 (GLOBE NEWSWIRE) —

Natera, Inc. NTRA

Lifshitz Law PLLC announces that a class action lawsuit has been filed on behalf of Natera shareholders alleging that the defendants misrepresented and/or failed to disclose: (i) the Company’s non-invasive panoramic prenatal test was unreliable and performed too high false positive rates; (ii) his Prospera test did not have superior precision compared to competing tests; (iii) Defendants’ false and misleading claims about Natera’s technology exposed the Company to significant legal and regulatory risks; (iv) Natera has relied on deceptive sales and billing practices to drive its revenue growth; and (v) as a result of the foregoing, Defendants’ statements about the Company’s business, operations and prospects were unfounded.

If you are a Natera investor and would like additional information about our investigation, please fill out Information Request Form or contact Joshua Lifshitz, Esq. by phone at (516) 493-9780 or by email info@jlclasslaw.com.

Butterfly Network, Inc. BFLY

Lifshitz Law PLLC announces that a class action lawsuit has been filed on behalf of Butterfly Network shareholders alleging that the company’s proxy statement relating to its merger with Longview was prepared through negligence and as a result falsely stated material facts or omitted to disclose other necessary ones Stating facts does not make the information given misleading. In addition, the lawsuit alleges that the defendants made false and/or misleading statements and/or failed to disclose the following: (i) Butterfly overstated its post-merger business and financial prospects; (ii) notwithstanding the ongoing COVID-19 pandemic, Butterfly’s financial projections have not taken into account the far-reaching consequences of the pandemic, which have included healthcare logistical challenges and medical staff fatigue; (iii) Accordingly, Butterfly’s gross margin and revenue projections were less sustainable…